Industry sponsorship bias in cost effectiveness analysis: registry based analysis

22 June 2022 - The Tufts Cost-Effectiveness Analysis Registry was used to identify all CEAs published in Medline between 1976 and ...

Read more →

Canada's regulator of patented drug prices is rigging data, and risking our health

5 December 2017 - The patent medicine pricing board is making a blatant attempt to bias the data. ...

Read more →